2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks...
2 days ago

While layoffs slowed in the second half of 2024, biopharmas including Bayer, Bristol Myers Squibb and Johnson & Johnson cut hundreds or even thousands of...
2 weeks ago

Companies including Bayer, Bristol Myers Squibb and Johnson & Johnson are cutting hundreds or even thousands of employees in 2024.
1 month ago

As companies like Pfizer, Johnson & Johnson, and Bayer announce job cuts, the sector pivots towards cost-cutting, pipeline refocusing, and leaner operations.
2 months ago

Five months into a restructuring at Takeda that has led to pipeline cuts and hundreds of layoffs, CEO Christophe Weber said the company's plans ...
2 months ago

Pharmaceutical management expert Kenneth Getz shares insights on broader trends in the pharma sector influencing the recent wave of layoffs.
2 months ago

The FDA's approval for Astellas' Vyloy, Otsuka's positive readout in a kidney disease and Samsung Biologics' largest contract made our news this week.
2 months ago

Layoff tracker: Pfizer axes 80 Kansas employees in second round of cuts this month, Takeda cuts more employees, total exceeds 1,300 in 2024. October 22.
2 months ago

Takeda, a Japanese pharmaceutical company with US headquarters in Cambridge, has announced the latest of several rounds of layoffs it's been conducting this...
2 months ago

Takeda, a Japanese pharmaceutical company with its US operations headquartered in Cambridge, announced additional layoffs Friday — and job cuts might continue...
2 months ago